HeartMate 3™ CE Mark Clinical Investigation Plan

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

March 9, 2020

Conditions
Advanced Refractory Left Ventricular Heart Failure
Interventions
DEVICE

Left Ventricular Assist System (LVAS)

Implantation of left ventricular assist device for hemodynamic support

Trial Locations (10)

4

Institute for Clinical and Experimental Medicine (IKEM), Prague

3181

The Alfred Hospital, Melbourne

13353

Deutsches Herzzentrum Berlin, Berlin

30625

Medizinische Hochschule Hannover, Hanover

32545

Herz- und Diabeteszentrum NRW Thorax- und Kardiovaskularchirurgie Clinic, Bad Oeynhausen

79106

Universitats-Herzzentrum Freiburg, Freiburg im Breisgau

A-1090

AKH Medical University of Vienna, Vienna

M5G-2C4

Toronto General Hospital, Toronto

04280

Herzentrum Leipzig GmbH, Leipzig

010000

National Research Center for Cardiac Surgery, Astana

All Listed Sponsors
collaborator

Center for Life Sciences

UNKNOWN

collaborator

Emergo

UNKNOWN

collaborator

KCRI

OTHER

collaborator

Thoratec Corporation

INDUSTRY

lead

Abbott Medical Devices

INDUSTRY

NCT02170363 - HeartMate 3™ CE Mark Clinical Investigation Plan | Biotech Hunter | Biotech Hunter